143 related articles for article (PubMed ID: 23392805)
21. [Overcoming acquired resistance to tumor necrosis factor-related apoptosis-inducing ligand by Bcl-XL small interfering RNA in human colon cancer].
Zhu HB; Huang XF; Hu JZ; Zhou W; Chen W; Chen LL; He C
Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):245-9. PubMed ID: 18788624
[TBL] [Abstract][Full Text] [Related]
22. TRAIL promotes metastasis of human pancreatic ductal adenocarcinoma.
Trauzold A; Siegmund D; Schniewind B; Sipos B; Egberts J; Zorenkov D; Emme D; Röder C; Kalthoff H; Wajant H
Oncogene; 2006 Nov; 25(56):7434-9. PubMed ID: 16751802
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.
Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T
BMC Cell Biol; 2006 Feb; 7():8. PubMed ID: 16504015
[TBL] [Abstract][Full Text] [Related]
24. Down-regulation of intracellular anti-apoptotic proteins, particularly c-FLIP by therapeutic agents; the novel view to overcome resistance to TRAIL.
Hassanzadeh A; Farshdousti Hagh M; Alivand MR; Akbari AAM; Shams Asenjan K; Saraei R; Solali S
J Cell Physiol; 2018 Oct; 233(10):6470-6485. PubMed ID: 29741767
[TBL] [Abstract][Full Text] [Related]
25. DR5-Cbl-b/c-Cbl-TRAF2 complex inhibits TRAIL-induced apoptosis by promoting TRAF2-mediated polyubiquitination of caspase-8 in gastric cancer cells.
Xu L; Zhang Y; Qu X; Che X; Guo T; Li C; Ma R; Fan Y; Ma Y; Hou K; Li D; Hu X; Liu B; Yu R; Yan H; Gong J; Liu Y
Mol Oncol; 2017 Dec; 11(12):1733-1751. PubMed ID: 28972304
[TBL] [Abstract][Full Text] [Related]
26. Impact of Extracellular pH on Apoptotic and Non-Apoptotic TRAIL-Induced Signaling in Pancreatic Ductal Adenocarcinoma Cells.
Hagelund S; Trauzold A
Front Cell Dev Biol; 2022; 10():768579. PubMed ID: 35281089
[TBL] [Abstract][Full Text] [Related]
27. Plasminogen activator urokinase expression reveals TRAIL responsiveness and supports fractional survival of cancer cells.
Pavet V; Shlyakhtina Y; He T; Ceschin DG; Kohonen P; Perälä M; Kallioniemi O; Gronemeyer H
Cell Death Dis; 2014 Jan; 5(1):e1043. PubMed ID: 24481457
[TBL] [Abstract][Full Text] [Related]
28. Silencing Daxx increases the anti-tumor activity of a TRAIL/shRNA Bcl-xL-expressing oncolytic adenovirus through enhanced viral replication and cellular arrest.
Kang S; Kang D; Bakhtiar Ul Islam SM; Je S; Kim JH; Song JJ
Cell Signal; 2015 Jun; 27(6):1214-24. PubMed ID: 25748050
[TBL] [Abstract][Full Text] [Related]
29. Cytoplasmic TRAIL-R1 is a positive prognostic marker in PDAC.
Gundlach JP; Hauser C; Schlegel FM; Böger C; Röder C; Röcken C; Becker T; Egberts JH; Kalthoff H; Trauzold A
BMC Cancer; 2018 Jul; 18(1):777. PubMed ID: 30064384
[TBL] [Abstract][Full Text] [Related]
30. The cyclin-dependent kinase inhibitor flavopiridol sensitizes human hepatocellular carcinoma cells to TRAIL-induced apoptosis.
Miyashita K; Shiraki K; Fuke H; Inoue T; Yamanaka Y; Yamaguchi Y; Yamamoto N; Ito K; Sugimoto K; Nakano T
Int J Mol Med; 2006 Aug; 18(2):249-56. PubMed ID: 16820931
[TBL] [Abstract][Full Text] [Related]
31. The expression of death receptor systems TRAIL-R1/-R2/-R4, CD95 and TNF-R1 and their cognate ligands in pancreatic ductal adenocarcinoma.
Gaertner F; Krüger S; Röder C; Trauzold A; Röcken C; Kalthoff H
Histol Histopathol; 2019 May; 34(5):491-501. PubMed ID: 30375637
[TBL] [Abstract][Full Text] [Related]
32. Glutamine-mediated epigenetic regulation of cFLIP underlies resistance to TRAIL in pancreatic cancer.
Kim JH; Lee J; Im SS; Kim B; Kim EY; Min HJ; Heo J; Chang EJ; Choi KC; Shin DM; Son J
Exp Mol Med; 2024 Apr; 56(4):1013-1026. PubMed ID: 38684915
[TBL] [Abstract][Full Text] [Related]
33. Thyroid hormone receptors promote metastasis of human hepatoma cells via regulation of TRAIL.
Chi HC; Chen SL; Liao CJ; Liao CH; Tsai MM; Lin YH; Huang YH; Yeh CT; Wu SM; Tseng YH; Chen CY; Tsai CY; Chung IH; Chen WJ; Lin KH
Cell Death Differ; 2012 Nov; 19(11):1802-14. PubMed ID: 22576662
[TBL] [Abstract][Full Text] [Related]
34. Upregulation of Death Receptor 5 and Production of Reactive Oxygen Species Mediate Sensitization of PC-3 Prostate Cancer Cells to TRAIL Induced Apoptosis by Vitisin A.
Shin D; Kwon HY; Sohn EJ; Nam MS; Kim JH; Lee JC; Ryu SY; Park B; Kim SH
Cell Physiol Biochem; 2015; 36(3):1151-62. PubMed ID: 26111475
[TBL] [Abstract][Full Text] [Related]
35. DJ-1 promotes invasion and metastasis of pancreatic cancer cells by activating SRC/ERK/uPA.
He X; Zheng Z; Li J; Ben Q; Liu J; Zhang J; Ji J; Yu B; Chen X; Su L; Zhou L; Liu B; Yuan Y
Carcinogenesis; 2012 Mar; 33(3):555-62. PubMed ID: 22223849
[TBL] [Abstract][Full Text] [Related]
36. Mutations in K-Ras linked to levels of osteoprotegerin and sensitivity to TRAIL-induced cell death in pancreatic ductal adenocarcinoma cells.
Kanzaki H; Ohtaki A; Merchant FK; Greene MI; Murali R
Exp Mol Pathol; 2013 Apr; 94(2):372-9. PubMed ID: 23219833
[TBL] [Abstract][Full Text] [Related]
37. High TRAIL death receptor 4 and decoy receptor 2 expression correlates with significant cell death in pancreatic ductal adenocarcinoma patients.
Sanlioglu AD; Dirice E; Elpek O; Korcum AF; Ozdogan M; Suleymanlar I; Balci MK; Griffith TS; Sanlioglu S
Pancreas; 2009 Mar; 38(2):154-60. PubMed ID: 18981952
[TBL] [Abstract][Full Text] [Related]
38. Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer.
Spano C; Grisendi G; Golinelli G; Rossignoli F; Prapa M; Bestagno M; Candini O; Petrachi T; Recchia A; Miselli F; Rovesti G; Orsi G; Maiorana A; Manni P; Veronesi E; Piccinno MS; Murgia A; Pinelli M; Horwitz EM; Cascinu S; Conte P; Dominici M
Sci Rep; 2019 Feb; 9(1):1788. PubMed ID: 30742129
[TBL] [Abstract][Full Text] [Related]
39. CD95 and TRAIL receptor-mediated activation of protein kinase C and NF-kappaB contributes to apoptosis resistance in ductal pancreatic adenocarcinoma cells.
Trauzold A; Wermann H; Arlt A; Schütze S; Schäfer H; Oestern S; Röder C; Ungefroren H; Lampe E; Heinrich M; Walczak H; Kalthoff H
Oncogene; 2001 Jul; 20(31):4258-69. PubMed ID: 11464292
[TBL] [Abstract][Full Text] [Related]
40. Ectopic expression of Bcl-2 and Bcl-xL inhibits apoptosis induced by TNF-related apoptosis-inducing ligand (TRAIL) through suppression of caspases-8, 7, and 3 and BID cleavage in human acute myelogenous leukemia cell line HL-60.
Lamothe B; Aggarwal BB
J Interferon Cytokine Res; 2002 Feb; 22(2):269-79. PubMed ID: 11911810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
